证券记录 · 已归档季度
MRK
Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
27被追踪持有人
0Δ持有人
972.48M持有股份
$81.66B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -0.9% · 净新建仓位 -3.7% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | 0 | 1.60B | $205.64B | +4 | −3 |
| Q1 2026 | 185 | +1 | 1.56B | $186.85B | +3 | −3 |
| Q4 2025 | 183 | 0 | 1.68B | $176.48B | +1 | — |
| Q3 2025 | 27 | 0 | 972.48M | $81.66B | +1 | −2 |
| Q2 2025 | 25 | 0 | 887.01M | $70.29B | +1 | −1 |
| Q1 2025 | 22 | -1 | 386.62M | $34.78B | — | −1 |
| Q4 2024 | 23 | -1 | 374.82M | $37.37B | — | −1 |
| Q3 2024 | 23 | +1 | 256.79M | $29.14B | +1 | — |
| Q2 2024 | 22 | — | 256.16M | $31.70B | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 252.14M | -0.3% | $21.16B | 0.3% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 214.88M | -1.6% | $18.03B | 0.3% | ▼ Trim | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 118.18M | -0.3% | $10.01B | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 75.28M | -2.0% | $6.32B | 1.1% | ▼ Trim | 6 | SEC ↗ ×9 |
| 5 | JPMorgan Chase ✦ | 70.40M | — | $5.91B | 0.2% | n/c | 1 | SEC ↗ ×46 |
| 6 | Geode Capital Management ✦ (被动) | 59.80M | +1.4% | $5.01B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 44.59M | — | $3.74B | 0.2% | n/c | 1 | SEC ↗ ×19 |
| 8 | Fidelity (FMR) ✦ | 33.43M | +5.9% | $2.81B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 9 | Fisher Asset Management ✦ | 24.07M | -3.8% | $2.02B | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 18.71M | -3.8% | $1.57B | 1.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 15.02M | — | $1.26B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 12 | T. Rowe Price ✦ | 13.60M | +26.0% | $1.14B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 10.66M | +21.3% | $851.37M | 0.5% | ▲ Add | 6 | SEC ↗ ×8 |
| 14 | Harris Associates (Oakmark) ✦ | 9.82M | +7.6% | $824.50M | 1.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | D. E. Shaw & Co. ✦ | 3.47M | -66.5% | $291.06M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 1.97M | -19.2% | $165.27M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 1.26M | +21671.6% | $105.98M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 1.05M | -26.1% | $88.43M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 968.05K | 新增 | $81.25M | 0.1% | New | 1 | SEC ↗ ×2 |
| 20 | Marshall Wace ✦ | 883.90K | -71.9% | $74.19M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Millennium Management ✦ | 763.37K | -22.9% | $64.07M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 592.31K | +23.6% | $49.71M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 513.94K | -55.3% | $43.14M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fairfax Financial ✦ | 172.90K | 0.0% | $14.51M | 0.7% | Held | 6 | SEC ↗ |
| 25 | Dodge & Cox ✦ | 154.28K | -1.9% | $12.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | GAMCO Investors ✦ | 63.06K | -8.9% | $5.29M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 27 | PRIMECAP Management ✦ | 46.00K | -11.4% | $3.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $81.25M | 0.1% |
已清仓
| Norges Bank | $2.86B | 曾为 0.4% |
| Renaissance Technologies | $11.07M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3,742 持有人, 1.88B 股份, $215.80B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Guindo Chirfi
Officer · 10.00K 股 · $1.35M
Aug 12
Zachary Jennifer
Officer · 80.31K 股 · $10.72M
Aug 12
DeLuca Richard R.
Officer · 11.10K 股 · $1.46M
Aug 12
DeLuca Richard R.
Officer · 600 股 · $79,222
Aug 11
DeLuca Richard R.
Officer · 5.43K 股 · $718,261
Aug 11
DeLuca Richard R.
Officer · 7.41K 股 · $973,165
Aug 10
DeLuca Richard R.
Officer · 20.78K 股 · $2.71M
Aug 06
DeLuca Richard R.
Officer · 805 股 · $105,472
Aug 06
DeLuca Richard R.
Officer · 4.95K 股 · $643,993
Aug 06
DeLuca Richard R.
Officer · 300 股 · $39,307
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据